期刊文献+

水飞蓟滨对大鼠体内伊马替尼药动学特征的影响

Effect of silybin on the pharmacokinetic characteristics of imatinib in rats
原文传递
导出
摘要 目的研究水飞蓟滨对大鼠体内伊马替尼药动学特征的影响。方法 20只♂SD大鼠随机分成2组,Ⅰ组按10 mg·kg^(-1)的剂量灌胃给予5 g·L^(-1)水飞蓟滨,Ⅱ组给予相同量的玉米油。1 h后2组大鼠按50mg·kg^(-1)的剂量灌胃给予5 g·L^(-1)伊马替尼。Ⅰ组和Ⅱ组分别在给药前和给药后0.5、1、2、3、4、6、8、12、24、36、48h时间点尾静脉采血。用HPLC法检测血浆中伊马替尼的浓度,并用DAS计算药动学参数。结果经灌胃给药后,伊马替尼在大鼠体内符合二室模型。Ⅰ、Ⅱ组血浆伊马替尼ρ_(max)分别为(11.77±1.98)和(14.68±2.55)m8·L^(-1),p_(max)分别为(3.00±0.68)和(3.30±0.68)h,AUC_(0→48)分别为(126.24±27.76)和(174.89±34.87)mg·h·L^(-1),AUC_(0→∞)分别为(128.43±27.74)和(178.07±35.46)mg·h·L^(-1),t_1/2α分别为(2.40±0.84)和(4.45±2.52)h,t_(1/2β)分别为(7.82±0.87)和(8.72±1.16)h。Ⅱ组伊马替尼的p_(max)比Ⅰ组增加了24.76%,AUC_(0→48)增加了38.54%,AUC_(0→∞)增加了38.65%,t_(1/2)相对延长。结论水飞蓟滨能增加伊马替尼的ρ_(max)和AUC,延长其t_(1/2),从而影响伊马替尼的代谢。 AIM To study the effect of silybin on the pharmacokinetic characteristics of imafinib in rats. METH- ODS Twenty male SD rats were divided at random into group I and group Ⅱ . Group I was given a single dose of 5 g· L- 1 silybin with intragastrie administration. Group Ⅱwas given the same amount of corn oil. Then 2 groups were given a single dose of 5 g· L-l imatinib with intragastric administration after 1 h. Blood samples were collected from the tail vein before administration and at 0.5,1,2,3,4,6,8,12,24,36 and 48 h points after irnatinib administration. The concentra- tion of imatinib in plasma was detected by HPLC method. The pharmacokinetic parameters were analyzed by DAS pro- gram. RESULTS After imatinib administration, imatinib was fitted to the two-compartment model in rats. The main pharmacokinetic parameters of group I and group II were as follows respectively: Pm~ were (11.77 ± 1.98) and ( 14.68 ± 2.55)mg · L- l, tmax were ( 3.00 ± 0.68) and ( 3.30 ± 0.68) h, AUC0→48 were ( 126.24 ± 27.76) and ( 174.89 ± 34.87) mg· h· L- 1, AUC0→∞ were( 128.43 ± 27.74) and( 178.07 ± 35.46) mg· h· L- 1, t1/2α were(2.40 ± 0.84) and(4.45 ± 2.52)h,and t1/2β were(7.82 ± 0.87) and(8.72 ± 1.16)h. When silybin and imatinib were co-ad- ministered, imatinib ρmax increased by 24.76%, AUC0→48 and AUC0→∞ increaed by 38.54% and 38.65 % respectively, and t1/2 were relatively extended. CONCLUSION Silybin could increase the p,~, and AUC of imatinib and extend the t1/2 of imatinib, then could effect the metabolism of imatinib in rots.
出处 《中国临床药学杂志》 CAS 2013年第1期19-22,共4页 Chinese Journal of Clinical Pharmacy
关键词 伊马替尼 水飞蓟滨 药动学 HPLC法 imatinib silybin pharmacokinetics HPLC
  • 相关文献

参考文献11

  • 1孙忠实,朱珠,韩风英.酪氨酸激酶抑制剂——伊马替尼[J].中国药学杂志,2003,38(1):69-71. 被引量:24
  • 2龙庆林,房殿春.胃肠道间质瘤发生的分子机制以及伊马替尼治疗研究进展[J].胃肠病学,2008,13(8):452-455. 被引量:5
  • 3尚雯,陶霞,刘皋林.伊马替尼在胃肠道间质瘤治疗中的应用[J].中国新药与临床杂志,2004,23(11):806-810. 被引量:5
  • 4冯慧琴,许祥稳,殳长林.拉米夫定、水飞蓟滨治疗乙肝肝硬化临床研究[J].中华全科医学,2010,8(1):55-55. 被引量:9
  • 5Petra JO, Eva A, Baibora PK, et al. Silybin is metabolized by cy-tochrome P450 2C8 in vitro [ J] . Drug Metab Dispos,2007,35 (11):2035. 被引量:1
  • 6Teoh M, Narayanan P, Moo KS, et al. HP1X deteimination of itnatinibin plasma and tissues after multiple oral dose dministrati<xi to mice[j].Pak J Phaim Sci,2010,23( 1):35. 被引量:1
  • 7Bende G, Kollipara S, Mowa S,et al. Validatiai an HPLC methodfor deteimination of imatinib mesylate in rat serum and its application ina pharmacokinetic sludy[j]. J Chromatogr Sci,2010,48(5) :334. 被引量:1
  • 8Parise RA, Ramanathan RK, Hayes MJ, et al. Liquid chromatographic-mass spectnxnetric assay for quantitaticm of imatinib and its main metabo-lite (CGP 74588) in plasma[j]. J Chrn?natogr B Analyt Technol BitmiedLifeSci,2003,791(l-2):39. 被引量:1
  • 9De Francia S, D* Avolio A, De Martino F, et al. New HPLC-MS methodfor the simultaneous quantification rf the antileukemia drugs imatinib,dasatinib, and nilotinib in human plasma [ J ]. J Chromatogr B AnalytTechnol Biomed Life Sci,2009,877( 18 - 19) : 1721. 被引量:1
  • 10Oostendoip RL, Beijnen JH, Schellens JH, et al. Determination of ima-tinib mesylate and its main n)etabolite (CGP74588) in human plasmaand murine specimens by ion-pairing reversed-phase high-performanceliquid chromatography [j] . 8ic?ned Chrcmiato^ ,2007,21 (7) :747. 被引量:1

二级参考文献33

  • 1陈正跃,吴子钊,许建文,张光军,程钢.水飞蓟宾-磷脂酰胆碱复合物与水飞蓟宾对四氯化碳所致小鼠急性肝损伤保护作用的对比[J].中国生化药物杂志,2004,25(4):221-223. 被引量:36
  • 2王宝恩,贾继东,张文胜.肝纤维化无创诊断模型的研究进展[J].中国中西医结合杂志,2006,26(1):5-7. 被引量:12
  • 3Yuen MF, Yuen HJ, Hui CK,et al. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatiis B infection : implications for antiviral therapy [ J ]. Gut, 2003,52 (3) :416-419. 被引量:1
  • 4Hang FK. Lamivudine treatment of decompensated hepatitis Bvirus-velated cirrhosis [ J ]. Hepatobiliary Pancreat Dis Int,2006,5 : 10-15. 被引量:1
  • 5Nozic D. Successful lamivudine therapy for chronic hepatitis B in the family[J]. Vojnosanit Pregl,2006,63:504-507. 被引量:1
  • 6-[5]See above 被引量:1
  • 7MIETTINEN M, SARLOMO-RIKALA M, LASOTA J. Gastrointestinal stromal tumors: recent advances in understanding of their biology [J]. Hum Pathol, 1999, 30(10): 1213-1220. 被引量:1
  • 8BERMAN J, O'LEARY TJ. Gastrointestinal stromal tumor workshop [J]. Hum Pathol, 2001, 32(6): 578-582. 被引量:1
  • 9de MATTEO RP, LEWIS JJ, LEUNG D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival [J]. Ann Surg, 2000, 231(1): 51-58. 被引量:1
  • 10SAVAGE DG, ANTMAN KH. Imatinib mesylate--a new oral targeted therapy [J]. N Engl J Med, 2002, 346(9): 683-693. 被引量:1

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部